Clinicopathological characteristics | Hazard ratio | 95.0% CI for Exp (B) | P value | |
---|---|---|---|---|
 |  |  | Lower | Upper |
Borrmann: | Â | Â | Â | Â |
I and II | 1 | Â | Â | Â |
III and IV | 0.78 | 0.21 | 2.85 | 0.7072 |
Histologic differentiation: | Â | Â | Â | Â |
Well and moderate | 1 | Â | Â | Â |
Poorly | 1.26 | 0.67 | 2.38 | 0.4756 |
Tumor size: | Â | Â | Â | Â |
<4 cm | 1 | Â | Â | Â |
≥4 cm | 1.17 | 0.63 | 2.18 | 0.6277 |
pT stage: | Â | Â | Â | Â |
pT1 and pT2 | 1 | Â | Â | Â |
pT3 and pT4 | 1.99 | 0.60 | 6.60 | 0.2595 |
Lymph node metastasis: | Â | Â | Â | Â |
Absence | 1 | Â | Â | Â |
Presence | 2.58 | 1.01 | 5.06 | 0.0480 |
TNM stage: | Â | Â | Â | Â |
I, II | 1 | Â | Â | Â |
III, IV | 2.70 | 1.06 | 7.03 | 0.0296 |
High-mobility group box 1 (HMGB1)expression: | Â | Â | Â | Â |
Negative | 1 | Â | Â | Â |
Positive | 2.66 | 1.04 | 6.32 | 0.0370 |
Vascular endothelial growth factor C (VEGF-C) expression: | Â | Â | Â | Â |
Negative | 1 | Â | Â | Â |
Positive | 2.62 | 1.03 | 6.83 | 0.0464 |
HMGB1 and VEGF-C | Â | Â | Â | Â |
Othersa | 1 | Â | Â | Â |
Combined HMGB1and VEGF-C expression | Â | Â | Â | Â |
 | 2.78 | 1.21 | 6.40 | 0.0162 |